Micro ribonucleic acid (miRNA) expression profile in non-small cell lung cancer (NSCLC) tissues in middle-altitude area was analyzed using the Affymetrix chip technique, to predict the target genes of abnormally-expressed miRNAs, and to analyze the target gene-related signaling pathways and cell biological functions regulated by them. The difference in miRNA expression profile in NSCLC tissues was analyzed using the Affymetrix chip technique. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was performed for the verification of some differentially-expressed miRNAs. The genes predicted by at least 6 out of 12 commonly used prediction methods of miRNA target genes, based on miRWalk2.0, were considered as target genes. The functions of differentially-expressed miRNA target genes were analyzed via Gene Ontology (GO) enrichment analysis, and the main signaling pathways involving target genes were analyzed via Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis. There was abnormal expression of miRNAs in NSCLC tissues in the middle-altitude area. There were 140,405 target genes predicted for differentially-expressed miRNAs. The GO enrichment analysis of the functions of the target genes of differentially expressed miRNAs revealed that they mainly influence the binding process of intracellular components to protein, the positive regulation of biological process and the regulation of metabolic process. Moreover, these target genes were mainly enriched in the immunity, gene expression, metabolism and signal transduction, among which signal transduction was enriched with the most genes. The expression levels of miRNA-139-5p and miRNA-150-5p in lung cancer group were lower than those in the control group. The expression of miRNAs in NSCLC tissues in the middle-altitude area is abnormal, and most miRNAs are downregulated.
Introduction
There are numerous diagnostic methods for lung cancer, such as sputum pathology, tumor markers, imaging, CT scan, percutaneous lung puncture, and fiberoptic bronchoscopic and surgical tissue biopsy. Sputum cytologic culture is a traditional diagnostic method with high diagnostic specificity of >98%, but the sensitivity is only 66% (1) . A trend toward lower sensitivity was noted for lesions that were <2 cm in diameter. However, sensitivity is higher for central lesions than for peripheral lesions. Therefore, for lesions <2 cm in diameter, CT is better than sputum cytology, especially in peripheral lung cancer. Although its diagnostic sensitivity is improved by cytologic smears, the arrangement mode of cancer cells is often changed during the smear process, harming the pathological diagnosis of lung cancer. There is a number of studies on the abnormal expression of micro ribonucleic acid (miRNA) in lung cancer tissues. However, the results are inconsistent or the biological functions remain unclear (1) (2) (3) . The abnormal expression of miRNA is also related to environment and genetics, which also have prognostic risks (4) . Whether the expression of miRNAs is inconsistent in lung cancer tissues and serum is unknown, and it has been reported that the miR-133 expression is increased in both lung cancer tissues and serum (5) . According to the MeDIP-chip microarray analysis, there is methylation of miRNAs (miR-10b, miR-1179, miR-137, miR-572, miR-3150b and miR-129-2) in primary lung tumor, and miR-1179 mimics prevent cell growth through inhibiting the target gene CCNE1 (6) .
miRNA is a kind of non-coding small-molecule RNA, which can target a variety of genes. miRNA is involved in regulating various biological processes, including the cell signal expression, proliferation, differentiation and apoptosis. Each miRNA can regulate hundreds of messenger RNAs (mRNAs) in a parallel and targeted manner, and any change in its expression level may produce significant influences on biological processes and lead to pathophysiological changes (7) . Tumor cells are in a special hypoxic microenvironment, and hypoxia will occur once the tumor diameter becomes more than several Expression profile of miRNA in NSCLC tissues in middle-altitude area hundred microns (8) . The production of hypoxic environment and the activation of its major effector, hypoxia-inducible factor-1 (HIF-1), are common features of advanced cancer (9) . Currently, there are few studies on whether the in vitro hypoxic state further aggravates the hypoxia in the microenvironment of lung cancer cells, and leads to abnormal expression of some miRNAs in lung cancer cells, and whether it is involved in the process of carcinogenesis, invasion and metastasis of lung cancer. A recent study found a significant correlation between Tibetan EGLN1/PHD2 haplotypes (D4E and C127S) and lung cancer, corresponding to a 2-fold increase of lung cancer risk in high altitude, and a ≥2-fold increased risk for rs117813469 and rs142764723 of the ten EPAS1/HIF-2α variants (10) , although the expression of miRNA is regulated by multiple factors. The tumor microenvironment, especially the effect of hypoxia on the biological characteristics of the tumor is clear.
In the present study, lung cancer patients in middle-altitude area were enrolled to observe the effect of environmental hypoxia and tumor on the expression of miRNA. GeneChip scanning was performed on lung cancer tissues of 4 patients with non-small cell lung cancer (NSCLC) and 5 patients of the control group in the middle-altitude area. The differentially expressed miRNAs in cancer tissues were screened, the target genes of differentially expressed miRNAs were predicted, and the target gene-related signaling pathways and cell biological functions regulated by them were analyzed. ) at room temperature for 25 min. Washing with PBS for 3 times, every 2 min followed. DAB chromogenic reagent was used to detect the protein expression for 3-10 min (ready-to-use DAB color liquid, microscopic control). The slides were subsequently stained with hematoxylin and bluing was carried out. Sliced tissues were conducted with graded alcohol dehydration and xylene following the manufacturer's instructions. Leica DM2500 optical microscope (Leica Microsystems, Ltd.) was used for observation. H&E staining in serial sections of each paraffin block specimens was performed for immunohistochemistry and expression analysis ( Fig. 1 ).
Patients and methods
GeneChip scanning of lung cancer tissues. Four patients diagnosed with NSCLC via pathological biopsy (E8, E2-t, E6-t and E9; Fig. 2A ), and 5 non-tumor patients (C6, C8, C5, C1 and C3; Fig. 2A ) were selected. The cancer and non-tumor tissues were collected and stored at -80˚C for Affymetrix GeneChip scanning (Affymetrix: Thermo Fisher Scientific, Inc.). Selection criteria for the lung cancer patients: i) Long-term residence in the middle-altitude area; ii) initial diagnosis of patients who did not receive any treatment (chemotherapy, molecular targeted therapy, or surgical resection); iii) patients with primary tumor; and iv) no other organ malignancy. Selection criteria for control patients: i) Patients with pneumothorax; and ii) no lung or other organ tumors. miRNAs were selected to expand the sample for verification, according to the following conditions: i) miRNAs consistently expressed according to the results of microarray and the published literature; ii) miRNAs with downregulated expression; and iii) miRNAs reported to be associated with lung cancer. miR-139-5p and miR-150-5p with obvious differential expression were verified by RT-qPCR with expanded sample size.
Statistical analysis
Chip difference analysis. The chip image information was converted into digital signal using the Affymetrix ® GeneChip ® Console ® software (Affymetrix: Thermo Fisher Scientific, Inc.). The probe signal was integrated into the probeset signal, and the inter-sample variation caused by non-biological factors was removed via inter-chip normalization. The data were preprocessed using Range Migration Algorithm (RMA) (13) . Differential genes were analyzed by Significance Analysis of Microarrays (SAM) R software package (https://www.rproject.org/), and the significant difference of chip data was analyzed. Differential genes were screened based on P<0.05 and fold change >2 or <0.5. Cluster analysis. Cluster analysis was performed for the differentially expressed miRNAs in the lung cancer and control groups using cluster software. Differentially expressed miRNAs were screened based on P<0.05 and fold change >2 or <0.5.
Prediction and analysis of target genes of differentially expressed miRNAs. The genes predicted by at least 6 out of 12 commonly used prediction methods of miRNA target genes (miRWalk, DIANA-microTv4.0, miRanda-rel2010, mirBridge, miRDB4.0, miRmap, miRNAMap, PicTar2, PITA, RNA22v2, RNAhybrid2 and Targetscan6.2), based on miRWalk2.0 (14), were considered as target genes.
Functional enrichment analysis. Functional enrichment analysis was performed for the target genes of differen tially expressed miRNAs using DAVID Bioinformatics Resources 6.7 (https://david.ncifcrf.gov/), including Gene Ontology (GO) enrichment analysis and pathway enrichment analysis (15) . GO enrichment includes biological process, cell component and molecular function. The functional regulation image was plotted using the CytoScape software (https://cytoscape.org/) and Bingo plug-in, followed by input of the target genes. Pathway enrichment analysis mainly referred to Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis (16) .
Data analysis. Experimental measurement data were expressed as the mean ± SD. SPSS 17.0 software (SPSS, Inc.) was used for statistical analysis. The log-rank P-values were obtained from a univariate Cox analysis, whereby miRNA expression was evaluated in response to patient survival time. Univariate Cox analysis also provided the Z-scores, which weighed the importance of the miRNA in response to these parameters. The t-test P-values were obtained from the Student's t-test, based on the patient vital status. Log 2 mean expression of the miRNA in the two survival cohorts was also obtained. The log-rank P-values were obtained from a univariate Cox analysis and survival characteristics of miRNA expression based on the Kaplan-Meier survival curves. The test level was set as α=0.05. P<0.05 was considered to indicate a statistically significant difference.
Results
Difference in miRNA expression profile of cancer tissues. The heatmap of gene expression in each group, obtained using the Cluster software, showed the difference in the expression of each gene in the different groups. Cluster analysis was performed for the miRNA expression in 4 cases in lung cancer group and 5 cases in normal group using the Cluster chip technique, and the differential genes were screened by the system according to the parameter setting and grouping, thus obtaining the distribution diagram ( Fig. 2A ) and list of differential genes. In the diagram with abscissa of log 2 (fold change) and ordinate of -log 10 (P-value), the data closer to the left and right bottom corresponded to the lower P-value, larger fold change and more significant difference ( Fig. 2B) . A total of 76 differentially expressed genes were screened, and no gene was upregulated (Table I) .
Prediction results of target genes of differentially expressed miRNAs. There were 140,405 target genes predicted by at least 6 out of 12 commonly used prediction methods of miRNA target Fig. 3) .
Enrichment analysis of predicted target genes of differentially expressed miRNAs. GO enrichment analysis and KEGG pathway enrichment analysis were performed for the target genes obtained.
GO enrichment analysis. The analysis of the functions of target genes of differentially expressed miRNAs via GO enrichment revealed that they mainly influenced the binding process of intracellular components to protein, the positive regulation of biological process and the regulation of metabolic process (Table Ⅱ and Fig. 4) .
KEGG enrichment analysis. KEGG pathway enrichment analysis showed that these target genes were mainly enriched in the immunity, gene expression, metabolism and signal KEGG pathway enrichment analysis showed that these target genes are mainly enriched in the immunity, gene expression, metabolism and signal transduction, among which signal transduction was enriched with the most genes. KEGG, Kyoto Encyclopedia of Genes and Genomes; miRNA, micro ribonucleic acid.
transduction, among which signal transduction was enriched with the most genes (Table Ⅲ and Fig. 5) . Disease enrichment analysis. The tenth disease enriched was cancer (Table Ⅳ and Fig. 6 ).
Comparison of miRNA-139-5p and miRNA-150-5p relative expression levels between the lung cancer and control group and its influence on prognosis.
According to RT-qPCR verification with an expanded sample size, the expression levels of miRNA-139-5p and miRNA-150-5p in lung cancer group were lower than those in control group, in accordance to the GeneChip results, displaying statistically significant differences (P<0.05) (Fig. 2C) . The use of online resources (http://www. oncomir.org/) predicted that low-expression miRNA-139-5p in lung squamous cell carcinoma and high-expression miRNA-150-5p in lung adenocarcinoma have a good prognosis (Tables V and Ⅵ, Fig. 2D and E) .
Discussion
NSCLC is a kind of solid tumor that is often diagnosed in the late stage, due to the lack of specific early symptoms, resulting in fewer opportunities for operation. Moreover, most of the samples in clinical survey are obtained via bronchoscopic small biopsy or cytology, so the number of tumor cells available is small with poor quality. miRNAs, as a kind of biomarkers, have expression dysregulation in the resected primary NSCLC tissues (17) , which plays important roles in the classification of lung cancer subtypes, prognosis of patient, and sensitivity to chemotherapy (18, 19) . In the present study, a comprehensive miRNA expression profile was identified, and abnormally expressed miRNAs in tumor tissues were confirmed, providing references for the in-depth research on the role of miRNAs in occurrence and development of tumors.
According to the systematic analysis of miRNA in various human cancers and 217 types of mammals, the miRNA profile has a surprising amount of information, reflecting the developmental lineage and differentiation status of tumors. miRNAs in tumors are generally downregulated, compared with those in normal tissues, and the miRNA expression profile is valuable for the classification of poorly differentiated tumors (20) . The results of this study are consistent with those in the above studies: All of the 76 differentially expressed miRNAs screened were downregulated, and no differentially expressed miRNAs were upregulated. miRNAs are a kind of non-coding regulatory RNAs involved in the occurrence of tumors and they display significant tissue specificity, which can serve as effective biomarkers for tracking the cancer of unknown origin (21) . Previous studies have demonstrated that the miRNA expression profile is correlated with the survival of lung adenocarcinoma. Univariate analysis has shown that the high expression of hsa-mir-155 and low expression of hsa-let-7a-2 are correlated with the low survival rate, while multivariate analysis have revealed that hsa-mir-155 is still related to the survival rate, and the miRNA expression profile is a diagnostic and prognostic marker for lung cancer (22) . The above results also suggest that the expression of miRNA in NSCLC is different from that of mRNA (23, 24) . The role of miRNA in the overall survival of patients with NSCLC has been analyzed currently, which may provide valuable information for the treatment of NSCLC (25) . However, its expression in lung cancer tissues was less consistent in the previous studies. Whether the lung cancer stage, case type and smoking status affect the results is worthy of further exploration and analysis. The low expression of cell adhesion molecule 1 (CADM1) is closely related to the short survival of NSCLC (26) , and it is essential to search for new markers.
In the present study, five miRNAs were selected and verified via RT-qPCR with an expanded sample size, and it was found that both miR-139-5p and miRNA-150-5p were downregulated, Table V . Cancer types where survival is significantly associated with miR-139-5p and miR-150-5p.
Log-rank
Deceased which is consistent with the GeneChip results. It is also reported that miR-139-5p is significantly downregulated in primary NSCLC tissues and cell lines. On the one hand, the ectopic expression of miR-139-5p significantly inhibits cell growth through suppressing the upregulation of cyclin D1 and p57 (Kip2), on the other hand, miR-139-5p induces apoptosis through upregulating cleaved caspase-3, a key apoptotic gene, and downregulating Bcl-2, an anti-apoptotic gene. In addition, miR-139-5p inhibits cell migration through inhibiting matrix metalloproteinase (MMP)-7 and MMP-9, and it was also found that miR-139-5p inhibits cell proliferation and metastasis promoting apoptosis through targeting oncogenic c-Met, thus playing a key role in lung cancer (27) . In primary NSCLC, the miR-139 silencing mediated by histone H3 lysine 27 trimethylation (H3K27me3) enhances the distant lymph node metastasis and histological invasion (lymphatic invasion and vascular invasion) of NSCLC (28) . Moreover, miR-139-5p inhibits in vitro proliferation, migration and invasion of lung cancer cells through targeting the insulin-like growth factor 1 receptor (IGF1R) (29) . miRNA-150-5p has not been reported in NSCLC in detail, however it has been reported that miRNA-150-5p and miRNA-34c-3p are closely related to skeletal muscle mitochondrial function in human body (30) , and the downregulation of miR-150-5p, a new circulating biomarker for acute heart failure (AHF), is correlated with the pathophysiology of AHF (31) . In multiple myeloma, miR-150-5p arouses the specific effect of glucocorticoid receptor (GR) to increase the therapeutic response of glucocorticoids through indirectly regulating the interaction of GR with transcription factors and GR chaperones and motivating mRNA of various effectors, protein stress and chemokines of GR (32) . In future research, the role of downregulation of miR-139-5p and miR-150-5p in NSCLC needs to be further clarified, and their specific values in target genes and functions should also be determined.
In the present study, the enrichment analysis of the functions of target genes of differentially expressed miRNAs revealed that they mainly influence the binding process of intracellular components to protein, the positive regulation of biological process and the regulation of the metabolic process. Moreover, KEGG pathway enrichment analysis showed that these target genes are mainly enriched in the immunity, gene expression, metabolism and signal transduction, among which signal transduction is enriched with the most genes. It was confirmed by previous studies that inhibiting miR-192 and miR-662 reduces the clonality and motility of early squamous cell carcinoma cells and increases the sensitivity to etoposide (33) . Downregulation of miR-30a-5p and upregulation of miR-210-3p in NSCLC have excellent sensitivity and acceptable specificity, which can assist in distinguishing cancer and non-cancer tissues (34) . The chronic treatment of NSCLC with gefitinib will alter the miRNA expression, including the significant decline in miR-155 and miR-200c accompanied by epidermal growth factor receptor (EGFR) mutation, and the decline in miR-155 and miR-200c may be correlated with epithelial-mesenchymal transition and histone modification, which may reduce the sensitivity to gefitinib, independent of the secondary EGFR mutation (35) . miRNA may play a role in immune escape, resistance to chemotherapeutic drugs and biological functions of lung cancer cells. Research on the roles of miR-139-5p and miR-150-5p in diagnosis, metabolism, signal transduction, biological behaviors and drug resistance in NSCLC will benefit the diagnosis and treatment of lung cancer patients, and may even bring an unexpected breakthrough in immunotherapy.
In conclusion, in the present investigation through GeneChip, it was revealed that miRNAs are mainly downregulated in the miRNA expression profile of lung cancer tissues in the middle-altitude area, which is not completely consistent with the miRNA expression difference in NSCLC tissues as reported by previous studies, indicating the individual difference and complexity of miRNA in pathogenesis. According to the verification with an expanded sample size, both miR-139-5p and miR-150-5p are downregulated, thus, deeply exploring their important roles in the occurrence and development of disease and regulation of tumor cell functions has great clinical value in the diagnosis, treatment and evaluation of lung cancer.
